Jul 2026· Journal of Artificial Intelligence and Digital Health· pp. 113· 0 citations
TL;DR
The proposed Nano–Bio–AI framework demonstrates how the synergistic integration of these technologies can support precision medicine through patient-specific therapeutic design and intelligent environmental management through pollutant detection, biodegradation, and ecosystem monitoring.
Abstract
The integration of nanotechnology, biotechnology, and artificial intelligence (AI) represents a transformative interdisciplinary approach for advancing biomedical and environmental applications. This study adopts a PRISMA-guided systematic literature review combined with conceptual framework development to synthesize current evidence on the convergence of these three technological domains and to propose an integrated Nano–Bio–AI framework. Relevant peer-reviewed literature was systematically identified, screened, and synthesized to examine the complementary roles of nanoscale engineering, biological system manipulation, and computational intelligence in addressing contemporary healthcare and environmental challenges.
The synthesized evidence indicates that nanotechnology enhances targeted drug delivery, diagnostic sensitivity, and controlled therapeutic release through engineered nanoscale materials. Biotechnology contributes bio-responsive systems, genetic engineering, and molecular manipulation techniques that enable precise biological interactions and adaptive therapeutic responses. Artificial intelligence complements these capabilities by applying machine learning and predictive analytics to large-scale biomedical and environmental datasets, thereby accelerating drug discovery, improving disease prediction, optimizing molecular interactions, and supporting evidence-based decision-making.
The proposed Nano–Bio–AI framework demonstrates how the synergistic integration of these technologies can support precision medicine through patient-specific therapeutic design and intelligent environmental management through pollutant detection, biodegradation, and ecosystem monitoring. The review also identifies key implementation challenges, including heterogeneous data integration, nanotoxicity, AI ethics, biosafety, and regulatory governance. Rather than providing empirical validation, the study offers a conceptually grounded framework derived from systematic evidence synthesis to guide future computational, experimental, and clinical research. Overall, the Nano–Bio–AI framework provides a comprehensive foundation for next-generation biomedical innovation and sustainable environmental technologies.
The integration of nanobiomaterials and synthetic biology has become an important research direction in modern biomedical engineering. Nanobiomaterials possess unique physicochemical properties, including high surface-area-to-volume ratios, excellent biocompatibility, and controllable drug release capabilities, while s...
Yong Zhou· Health and Molecular Frontie...· 0 citations
Cancer nanomedicine offers a versatile platform for improving therapeutic index, but its clinical translation remains limited by unpredictable in vivo behavior, heterogeneous biological contexts, and inefficient design paradigms. Artificial intelligence (AI) is emerging as an integrative framework that links data‐drive...
Sheng-Bin Liu, Zhi Liu, Haixing Shi et al.· MedComm· 0 citations
This review provides a structured overview of AI applications in nanotechnology, including data-driven nanomaterial discovery and inverse design using machine learning (ML) and generative models, optimization of nanoparticle synthesis through Bayesian optimization and self-driving laboratories, targeted drug delivery a...
Biomaterials are indispensable to modern healthcare, yet their development remains hindered by traditional trial-and-error approaches that are costly, time-intensive, and inefficient. Artificial intelligence (AI) offers a powerful alternative, but most existing reviews treat AI merely as a computational tool for proper...
Yi-Chen Liu, Zhi-Ting Wang, Hao-Jie Wei et al.· Journal of Biomedical Materi...· 1 citation
OBJECTIVE
This review presents Darwinian nanomedicine as an artificial intelligence (AI)-enabled drug delivery strategy that applies Darwinian evolutionary principles as a computational and engineering analogy. Rather than implying biological evolution of nanoparticles, the framework employs iterative cycles of variati...
C. Belkare, O. Daware· Drug Development and Industr...· 0 citations
Artificial Intelligence (AI) has become a fundamental driver of scientific progress, particularly in disease diagnosis, drug development, and drug delivery optimization. The intersection of AI, drug design, and nanosystems for delivery is accelerating the advancement of personalized nanomedicines and innovative dianano...